{"slideshow_credits": null, "snippet": "Endo International, a pharmaceutical company that reincorporated in Ireland, is now trying to stop an inversion by smaller rival, Auxilium Pharmaceuticals.", "abstract": "Endo International, a pharmaceutical company that reincorporated in Ireland, is now trying to stop an inversion by smaller rival, Auxilium Pharmaceuticals.", "section_name": "Business Day", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"firstname": "David", "role": "reported", "lastname": "GELLES", "rank": 1, "organization": ""}], "original": "By DAVID GELLES"}, "web_url": "http://dealbook.nytimes.com/2014/09/16/drug-maker-that-did-an-inversion-seeks-to-block-one/", "lead_paragraph": null, "headline": {"main": "Drug Maker That Did an Inversion Seeks to Block One", "print_headline": "Auxilium Bid", "kicker": "DealBook"}, "_id": "5418aec938f0d86afc9a0652", "word_count": "423", "multimedia": [], "pub_date": "2014-09-16T17:40:35Z", "source": "The New York Times", "news_desk": "Business", "keywords": [], "blog": [], "subsection_name": "Dealbook", "type_of_material": "Blog"}